Overview Open-label Study of Liothyronine in MS Status: Completed Trial end date: 2017-09-18 Target enrollment: Participant gender: Summary This study will evaluate the safety and tolerability of synthetic T3, liothyronine. It will establish if there are changes in MS symptoms and if there is a positive effect on markers of neuronal health. Phase: Phase 1 Details Lead Sponsor: Johns Hopkins University